Related Tags >> milestones Phase II Anemia drugs Takeda

Affymax News

Most Popular Affymax Story

DEALS: J&J buys Pfizer's OTC division for $16.6B

July 5, 2006 — 8:01pm ET

J&J buys Pfizer's OTC division for $16.6B

... Read more...

Affymax Press Releases

Affymax, Inc. (AFFY) to Stop Trial for Chemotherapy-Induced Anemia

Latest Headlines

Affymax, Takeda suspend ESA development
August 29, 2008
ALSO NOTED: FDA OKs Novalar therapy; StemCells files new patent suit; and much more...
May 12, 2008
Press Release: Affymax Receives $10 Million Milestone Payment
February 1, 2007
Press Release: Affymax Receives $10 Million Milestone Payment
February 1, 2007
ALSO NOTED: Quest Diagnostics buys HemoCue; Affymax pockets $10M milestone;Pozen to file response on Trexima; and much more...
January 31, 2007
ALSO NOTED: Elan, Biogen submit Tysabri for Crohn's; Affymax prices IPO;and much more...
December 14, 2006
Press Release: Affymax Announces IPO
December 14, 2006
ALSO NOTED: Glaxo wins approval for Hycamtin; Affymax forecasts share price;The best (and worst) biotech stocks of 2006; and mu
November 30, 2006
DEALS: AstraZeneca, Pozen in $375M licensing deal
August 2, 2006
SPOTLIGHT: Affymax files IPO
July 30, 2006
ALSO NOTED: TransPharma raises $18M; Biogen Idec, Elan re-release Tysabri; and much more...
July 23, 2006
DEALS: J&J buys Pfizer's OTC division for $16.6B
July 5, 2006
Takeda licenses Hematide in $535M deal
June 26, 2006
C&L: Phase III Medical taps Robin Smith as CEO
June 6, 2006
ALSO NOTED: Takeda licenses Hematide; Lectus garners £8.2M; YM shares gain on fast-track announcement;and much more...
February 12, 2006
ALSO NOTED: Albany Molecular buys ComGenex; Iomai cuts IPO price; and much more...
January 29, 2006
VC: Affymax leads venture rounds with $60M
July 27, 2005
Affymax pockets $60M in fourth VC round
July 17, 2005

Paid Research Reports